Use of sucralfate in renal failure

Annals of Pharmacotherapy

Volumn 35, Issue 3, 2001, Pages 360-364

  Hemstreet, B A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

End stage renal disease; Renal failure; Sucralfate

Indexed keywords

ACETYLSALICYLIC ACID; ALUMINUM DERIVATIVE; ALUMINUM HYDROXIDE; ANTACID AGENT; ANTIDIARRHEAL AGENT; ANTIULCER AGENT; CALCIUM ACETATE; CALCIUM CARBONATE; HISTAMINE H2 RECEPTOR ANTAGONIST; PHOSPHATE BINDING AGENT; PROTON PUMP INHIBITOR; RANITIDINE; SEVELAMER; SUCRALFATE;

APRAXIA; BONE DISEASE; DIALYSIS ENCEPHALOPATHY; DOSE KIDNEY FUNCTION RELATION; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CONTRAINDICATION; DRUG EXCRETION; DYSARTHRIA; FLAPPING TREMOR; HUMAN; KIDNEY FAILURE; LONG TERM EXPOSURE; MYOCLONUS; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0035093587     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10117     Document Type: Review

References (27)

1. Gastrointestinal absorption of aluminum in chronic renal insufficiency
2. Aluminum toxicology and the aluminum-containing medications
3. Aluminum intake from non-prescription drugs and sucralfate
4. Aluminum and chronic renal failure: Sources, absorption, transport, and toxicity
5. Diagnosis and treatment of aluminum bone disease
6. Aluminum toxicity in dialysis patients: No evidence for a threshold serum aluminum concentration
7. Consensus conference: Diagnosis and treatment of aluminum overload in end-stage renal failure patients
8. Sucralfate
9. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease
10. Gastrointestinal absorption of aluminum from single doses of aluminum-containing antacids in man
11. Metabolism and toxicity of aluminum in renal failure
12. Plasma aluminum levels of patients on long-term sucralfate therapy
13. Urinary excretion of aluminum after ingestion of sucralfate and an aluminum-containing antacid in man
14. Elevation of serum aluminum in humans on a two-day sucralfate regimen
15. Plasma and urine aluminum concentrations in healthy subjects after administration of sucralfate
16. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers
17. Aluminum hydroxide versus sucralfate as a phosphate binder in uremia
18. Phosphate-binding effects of sucralfate in patients with chronic renal failure
19. Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency
20. Plasma aluminum concentrations in long-term mechanically ventilated patients receiving stress ulcer prophylaxis with sucralfate
21. Accelerated development of hypercalcemic aluminum-associated bone disease in a patient with protracted acute renal failure
22. Encephalopathy in patient taking aluminum-containing agents, including sucralfate
23. Acute aluminum encephalopathy in a uremic patient
24. Aluminum toxicity and absorption from sucralfate: A potential complication in patients with renal failure
25. Sucralfate, intestinal aluminum absorption, and aluminum toxicity in a patient on dialysis
26. Aluminum toxicity from oral sucralfate therapy
27. Sucralfate-associated aluminum toxicity in a patient with renal failure: Treatment with deferoxamine